Olodaterol exerts anti-inflammatory effects on COPD airway epithelial cells

Olodaterol exerts anti-inflammatory effects on COPD airway epithelial cells

Abstract Background Airway inflammation is a key feature of chronic obstructive pulmonary disease (COPD) and inhaled corticosteroids (ICS) remain the main treatment for airway inflammation. Studies have noted the increased efficacy of ICS and long-acting beta 2 agonist (LABA) combination therapy in...

Full description

Bibliographic Details
Main Authors: Nan Yang, Gurpreet K. Singhera, Yi Xuan Yan, Michael P. Pieper, Janice M. Leung, Don D. Sin, Delbert R. Dorscheid
Format: Article
Language:English
Published: BMC 2021-02-01
Series:Respiratory Research
Subjects:
Airway epithelium
Interleukin-8
Airway inflammation
Olodaterol
Long-acting beta agonist
COPD
Online Access:https://doi.org/10.1186/s12931-021-01659-2

Internet

https://doi.org/10.1186/s12931-021-01659-2

Similar Items